KCM
SGNT

Kennedy Capital Management’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Kennedy Capital Management’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-458,943
Closed -$6.88M – 788
2016
Q2 		$6.88M Sell
458,943
-14,330
-3% -$184K 0.14% 262
2016
Q1 		$5.76M Buy
473,273
+211,069
+80% +$2.96M 0.12% 311
2015
Q4 		$4.17M Buy
262,204
+52,558
+25% +$827K 0.08% 413
2015
Q3 		$3.21M Buy
209,646
+27,575
+15% +$596K 0.07% 472
2015
Q2 		$4.43M Buy
182,071
+46,668
+34% +$1.12M 0.08% 423
2015
Q1 		$3.15M Buy
+135,403
New +$3.58M 0.06% 503

Kennedy Capital Management's SGNT Position: Q3 2016 in Review

Kennedy Capital Management sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 458,943 shares — an estimated $6.88M sold.

Kennedy Capital Management first reported a position in SGNT in Q1 2015 and held it in 6 quarters. The position peaked at $6.88M in Q2 2016. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

  • Kennedy Capital Management reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • Kennedy Capital Management sold 458,943 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $6.88M.
  • Kennedy Capital Management first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q1 2015 and held it in 6 quarters.
  • Kennedy Capital Management's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $6.88M in Q2 2016.
  • 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on Kennedy Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.